Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Shubang Pharmaceutical is a specialized pharmaceutical manufacturer based in Quzhou, China, focusing on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company is a significant supplier of chemical building blocks for cardiovascular drugs, particularly the statin family, including Atorvastatin, Rosuvastatin, and Pitavastatin. Shubang Pharmaceutical operates GMP-compliant facilities and provides contract development and manufacturing organization (CDMO) services to the global life sciences industry. Its core expertise lies in complex organic synthesis and large-scale chemical production for the pharmaceutical sector. The company maintains a strong focus on quality control and process optimization to meet international regulatory standards. It serves as a critical link in the global supply chain for essential cardiovascular therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shubang Pharmaceutical.